BACKGROUND: Evidence from open label studies has indicated that patients with dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) do better than those with other diagnoses, including Alzheimer's disease (AD). In addition, those with dementia of moderate severity do better than those with mild severity. METHOD: Data collected for the monitoring of cholinesterase inhibitor prescribing in Oxfordshire over four years were supplemented with retrospective case notes inspection. ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice.
If you are the owner of this record, you can report an update to it here: Report update to this record